- Close review of MRI scans found more intensive high blood pressure treatment (targeted to achieve a systolic pressure less than 120 mm Hg) was more effective than a less-intense treatment goal of 140 mm Hg systolic in achieving a positive structural change in the brain’s perivascular spaces: pathways that are important to clearing toxins and other byproducts.
- If the brain cannot properly clear metabolic byproducts, they accumulate and may contribute to the development of dementia, researchers said.
- The new findings are from MRI scans of several hundred adults in the SPRINT-MIND trial that previously found intensive blood pressure-lowering slowed cognitive impairment.
Embargoed until 4 a.m. CT/5 a.m. ET, Thursday, Feb. 2, 2023
DALLAS, Feb. 2, 2023 — Among people who received more intensive treatment for high blood pressure, evaluations of MRI scans indicated a positive change in brain structures involved in its ability to clear toxins and other byproducts, according to preliminary research to be presented at the American Stroke Association’s International Stroke Conference 2023. The meeting, held in person in Dallas and virtually, Feb. 8-10, 2023, is a world premier meeting for researchers and clinicians dedicated to the science of stroke and brain health.
The study is the first to examine whether intensive blood pressure treatment may slow, or reverse structural changes related to the volume of the brain’s perivascular spaces, areas of the brain around the blood vessels that are involved in the clearance of toxins and other byproducts. These areas tend to enlarge as people get older or have more cardiovascular risk factors.
“If the brain cannot properly clear toxins and metabolic byproducts, they will accumulate and may contribute to the development of dementia,” said Kyle Kern, M.D., M.S., lead author of the study and a clinical research fellow in the intramural stroke branch of the National Institute of Neurological Disorders and Stroke, a division of the National Institutes of Health in Bethesda, Maryland. “Some research has proposed that the pulsations of the cerebral arteries with each heartbeat help to drive the clearance of these toxic brain byproducts in the perivascular spaces. However, high blood pressure over the long term stiffens arteries, impairing function and the ability to clear toxins, resulting in enlargement of perivascular spaces.”
The researchers analyzed brain MRI scans for 658 participants (average age of 67 years, 60% women) of the SPRINT-MIND MRI substudy. The trial began in 2010, and the last MRI scan was completed in July 2016. All participants had high blood pressure but none had previously been diagnosed with diabetes (Type 1 or 2), dementia or stroke.
After an average 3.9-year follow-up period, 243 people in the intensive treatment group (systolic blood pressure goal of 120 mm Hg) and 199 people in the standard treatment arm (systolic blood pressure goal of 140 mm Hg) had pre– and post–MRI scans that were analyzed for the percentage of brain tissue taken up by perivascular spaces. Participants were screened at seven MRI sites across the U.S.: University of Alabama at Birmingham, Boston University, Vanderbilt University, Wake Forest University, University of Miami, University of Pennsylvania and Case Western Reserve University.
In MRI scans taken when the study began, the percentage of brain tissue occupied by perivascular spaces was higher among the patients who were older and had a greater volume of white matter hyperintensities (areas of increased brightness on an MRI scan that are the best-established marker of damage to small blood vessels in the brain). These patients also had more brain atrophy, another marker of aging and declining brain health.
After controlling for age and sex of the participants, and the study site where the MRIs were performed, the analysis found:
- At the start of the study, the volume of perivascular spaces was similar among participants in both blood pressure treatment groups.
- After almost 4 years of high blood pressure treatment, the volume of perivascular spaces had decreased significantly in the intensive treatment group but did not change in the standard treatment group.
“Previous research has confirmed that effective blood pressure control is important for brain health. Our secondary analysis findings from SPRINT-MIND MRI suggest that intensive blood pressure control may be beneficial by reducing damage to the brain’s toxin and byproduct clearance pathway,” Kern said.
While the original SPRINT-MIND MRI study demonstrated that intensive blood pressure control may slow the accumulation of white matter hyperintensities, this substudy found that it may contribute to reversing the effects of high blood pressure on perivascular spaces.
“These results also suggest that perivascular spaces are more dynamic, and further research is needed to determine the relationship between perivascular space change and the progression of white matter hyperintensities,” Kern said.
The study is limited to the data available and the scope of knowledge that can be interpreted from the data. This includes not being able to determine whether the change in perivascular spaces improves thinking ability, or if it is a byproduct of blood pressure treatment that has no cause-and-effect relationship to cognition or cognitive decline.
“The next step is to determine how perivascular spaces relate to cognition and cognitive decline in the SPRINT-MIND trial. That trial included high-quality cognitive function assessments at multiple time points, and forthcoming investigations from the trial will describe how perivascular spaces may relate to the effect of intensive blood pressure control on cognitive decline,” Kern said.
According to the American Heart Association, normal blood pressure is below 120/80 mm Hg. For adults, if systolic pressure (the top number) is 120 to 129 mm Hg, and diastolic pressure is less than 80 mm Hg, this is classified as elevated blood pressure. High blood pressure is a systolic pressure of 130 mm Hg or higher, or a diastolic pressure of 80 mm Hg or higher, that stays high over time.
“These novel findings provide early evidence that it may be possible to reduce perivascular space size by intensive systolic blood pressure lowering. While not yet proven, the implication is that the intensive systolic blood pressure lowering may eventually be associated with better clearance of brain toxins and metabolic by-products and thus, provide a better chance to maintain brain health,” said Philip B. Gorelick, M.D., M.P.H., FAHA, chair of the American Heart Association’s Stroke Brain Health Science Subcommittee and professor of neurology in the Ken & Ruth Davee Department of Neurology at Northwestern University’s Feinberg School of Medicine in Chicago, who was not involved in the study.
Co-authors are Ilya M. Nasrallah, M.D., Ph.D., and Clinton B. Wright, M.D., M.S. Authors’ disclosures are listed in the abstract.
The study was funded by the National Institute of Neurological Disorders and Stroke, a division of the National Institutes of Health.
Statements and conclusions of studies that are presented at the American Heart Association’s scientific meetings are solely those of the study authors and do not necessarily reflect the Association’s policy or position. The Association makes no representation or guarantee as to their accuracy or reliability. Abstracts presented at the Association’s scientific meetings are not peer-reviewed, rather, they are curated by independent review panels and are considered based on the potential to add to the diversity of scientific issues and views discussed at the meeting. The findings are considered preliminary until published as a full manuscript in a peer-reviewed scientific journal.
The Association receives funding primarily from individuals; foundations and corporations (including pharmaceutical, device manufacturers and other companies) also make donations and fund specific Association programs and events. The Association has strict policies to prevent these relationships from influencing the science content. Revenues from pharmaceutical and biotech companies, device manufacturers and health insurance providers and the Association’s overall financial information are available here.
- Video Perspective from Philip B. Gorelick, M.D., M.P.H., FAHA and additional multimedia are available on the right column of the release link https://newsroom.heart.org/news/ideal-blood-pressure-may-remodel-brain-clearance-pathways-linked-to-brain-health-dementia?preview=bc6ee229f0d06669f643af985511d37b
- Abstracts on ASA’s International Stroke Conference 2023 Online Program Planner
- ASA news release: Brain images show less injury and look healthier in adults with heart-healthy lifestyle (Feb. 2022)
- ·ASA news release: Earlier onset of high blood pressure affects brain structure, may increase dementia risk (Oct. 2021)
- For more news at ASA International Stroke Conference 2023, follow us on Twitter @HeartNews #ISC23
The American Stroke Association’s International Stroke Conference (ISC) is the world’s premier meeting dedicated to the science and treatment of cerebrovascular disease. ISC 2023 will be held in person in Dallas and virtually, Feb. 8-10, 2023. The three-day conference will feature more than a thousand compelling presentations in categories that emphasize basic, clinical and translational sciences as research evolves toward a better understanding of stroke pathophysiology with the goal of developing more effective therapies. Engage in the International Stroke Conference on social media via #ISC23.
About the American Stroke Association
The American Stroke Association is devoted to saving people from stroke — the No. 2 cause of death in the world and a leading cause of serious disability. We team with millions of volunteers to fund innovative research, fight for stronger public health policies and provide lifesaving tools and information to prevent and treat stroke. The Dallas-based association officially launched in 1998 as a division of the American Heart Association. To learn more or to get involved, call 1-888-4STROKE or visit stroke.org. Follow us on Facebook, Twitter.
For Media Inquiries and AHA Expert Perspective:
AHA Communications & Media Relations in Dallas: 214-706-1173; firstname.lastname@example.org
Karen Astle: 214-706-1392; Karen.email@example.com
For Public Inquiries: 1-800-AHA-USA1 (242-8721)
heart.org and stroke.org